Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RLMD | US
0.08
2.35%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
3.48
3.35
3.60
3.33
Relmada Therapeutics Inc. a clinical-stage biotechnology company focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone dextromethadone and REL-1017) a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
41.0%1 month
92.2%3 months
113.5%6 months
88.3%-
-
1.65
-
-
0.54
-
-
-161.25M
105.01M
105.01M
-
-
-
-
-100.41
9.05
3.98
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.54
Range1M
1.60
Range3M
2.59
Rel. volume
0.56
Price X volume
592.79K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.7699 | 112.70M | 2.15% | n/a | 36.36% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.8874 | 110.64M | 0.40% | n/a | -148.05% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.14 | 108.68M | 1.79% | n/a | 30.76% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.7107 | 107.16M | 5.95% | n/a | -294.40% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 9.48 | 95.62M | -7.06% | n/a | 0.00% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.87 | 85.58M | 2.75% | n/a | 41.98% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.44 | 54.51M | 0.70% | n/a | 25.73% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.1014 | 42.58M | 4.54% | n/a | 0.00% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.24 | 38.49M | -7.46% | n/a | 318.92% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3705 | 28.02M | -3.89% | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Culp Inc | CULP | Textile Manufacturing | 5.95 | 74.32M | -2.30% | n/a | 11.29% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.33 | 5.20M | 0.03% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.54 | 17.21 | Cheaper |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | 1.65 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 113.55 | 68.34 | Riskier |
Debt to Equity | - | -1.00 | - |
Debt to Assets | - | 0.48 | - |
Market Cap | 105.01M | 5.31B | Emerging |